Dirk Kocher is “well versed” in complex restructurings and corporate governance issues.The Legal 500 EMEA 2015

Dirk Kocher

Hamburg
  • Warburgstrasse 50
  • 20354 Hamburg
  • Germany
 
 

Dr. Dirk Kocher is a partner in the Hamburg office of Latham & Watkins and practices in the firm’s Corporate Department, focusing on public and private M&A, stock corporation, and capital markets law as well as restructurings. He advises corporations, private equity, and strategic investors on all related matters. This includes in particular:

  • Acquisition and sale of stakes in listed corporations and other companies
  • Taking privates and capital markets transactions
  • Corporate governance, reorganizations, and capital markets’ compliance 
  • Loan-to-own and other restructurings

He also has extensive experience with joint ventures and shareholder disputes.

Mr. Kocher is a former vice chairman of the board of the Finnish-German Trade Association in Hamburg and a lecturer at Bucerius Law School (Hamburg). He regularly publishes on corporate and capital markets law issues and is a frequent speaker at seminars and conferences on these topics.

Mr. Kocher has been "repeatedly recommended" for Corporate Law (BUJ Kanzleimonitor 2015/2016). He is also currently listed in Chambers Global as a notable practitioner for Corporate/M&A, not only for Germany but — as a foreign expert — also for Finland. He is “recognized as a prominent figure in cross-border corporate cases” (2014).

Mr. Kocher had a lead role on Rhön-Klinikum’s €3 billion sale of a portfolio of major assets and subsequent innovative share buyback, which was honored inter alia by The Lawyer as European Corporate Deal of the Year 2015.

Dr. Dirk Kocher’s experience includes advising:

  • Novo A/S on strategic PIPE investment in listed German Evotec AG by way of a capital increase (private placement)
  • Aliaxis S.A. on mandatory bid for and subsequent squeeze-out of Friatec AG
  • Capvis Equity Partners AG in the acquisition of the majority stake in listed WMF Württembergische Metallwarenfabrik AG and the subsequent sale to KKR
  • Corsair Capital LLC on capital increases of MPC Capital AG including on exemption from the mandatory tender duty
  • Deutsche Bank AG, London, in the restructuring of listed German corporations, including debt-equity swaps (Deutsche Steinzeug Cremer & Breuer AG, Vivanco-Gruppe AG) 
  • Senior Creditors’ Committee regarding the loan-to-own restructuring of Honsel AG
  • HBOS Group on capital increase of MLP AG
  • Kalina International S.A. on delisting, squeeze-out and subsequent sale of Dr. Scheller Cosmetics AG
  • Nord Pool ASA on sale of a stake in EEX AG
  • Rhön-Klinikum AG on its €3.07 billion sale of major assets to Fresenius Helios and on its share buyback program with tender rights admitted to trading on the stock exchange and a volume of approx. €1.7 billion
  • German listed stock corporations in shareholder disputes (e.g., Klöckner-Werke AG, WCM AG, FAME AG, Friatec AG, Dr. Scheller Cosmetics AG, Röhn-Klinikum AG)
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.